Track Order  |   Orders Outside India   |   Institutional Purchase   | Customers' Google Reviews : 4.7  
×







We sell 100% Genuine & New Books only!

Quantitative Drug Safety and Benefit Risk Evaluation 1st Edition 2021 Hardbound at Meripustak

Quantitative Drug Safety and Benefit Risk Evaluation 1st Edition 2021 Hardbound by William Wang , Melvin Munsaka , James Buchanan , Judy Li , CRC Press

Books from same Author: William Wang , Melvin Munsaka , James Buchanan , Judy Li

Books from same Publisher: CRC Press

Related Category: Author List / Publisher List

  • Price: ₹ 13212.00/- [ 17.00% off ]

    Seller Price: ₹ 10966.00

Estimated Delivery Time : 4-5 Business Days

Sold By: Meripustak      Click for Bulk Order

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

We deliver across all postal codes in India

Orders Outside India


Add To Cart

Outside India Order Estimated Delivery Time
7-10 Business Days

  • We Deliver Across 100+ Countries
  • MeriPustak’s Books are 100% New & Original
    • General Information  
    Author(s)William Wang , Melvin Munsaka , James Buchanan , Judy Li
    PublisherCRC Press
    Edition1st Edition
    ISBN9781138594067
    Pages382
    BindingHardbound
    LanguageEnglish
    Publish YearDecember 2021

    Description

    CRC Press Quantitative Drug Safety and Benefit Risk Evaluation 1st Edition 2021 Hardbound by William Wang , Melvin Munsaka , James Buchanan , Judy Li

    Covers four pillars of safety statistics: cross-disciplinary scientific engagement, effective and efficient operational process, visual analytics, and intelligent data architectureLinks safety monitoring to benefit risk evaluationPresents an emerging topic that links to ICH E19 and TransCelerate safety efforts


    Mathematics & Statistics
    Mental Mathematics

    Book Successfully Added To Your Cart